These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6743082)

  • 1. Visual field defects in ocular hypertension and glaucoma.
    Neima D; LeBlanc R; Regan D
    Arch Ophthalmol; 1984 Jul; 102(7):1042-5. PubMed ID: 6743082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flicker defined form perimetry in glaucoma suspects with normal achromatic visual fields.
    Reznicek L; Lamparter J; Vogel M; Kampik A; Hirneiß C
    Curr Eye Res; 2015 Jul; 40(7):683-9. PubMed ID: 25207744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motion automated perimetry identifies early glaucomatous field defects.
    Bosworth CF; Sample PA; Gupta N; Bathija R; Weinreb RN
    Arch Ophthalmol; 1998 Sep; 116(9):1153-8. PubMed ID: 9747672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse and localized glaucomatous field loss in light-sense, flicker and resolution perimetry.
    Lachenmayr BJ; Drance SM; Chauhan BC; House PH; Lalani S
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):267-73. PubMed ID: 1869065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):645-50. PubMed ID: 8489447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency distribution of earliest glaucomatous visual field defects documented by automatic perimetry.
    Heijl A; Lundqvist L
    Acta Ophthalmol (Copenh); 1984 Aug; 62(4):658-64. PubMed ID: 6485761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of frequency doubling perimetry and polarimetric measurements of retinal nerve fiber layer in glaucoma detection.
    Horn FK; Nguyen NX; Mardin CY; Jünemann AG
    Am J Ophthalmol; 2003 Feb; 135(2):160-8. PubMed ID: 12566019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma.
    Hawkins AS; Szlyk JP; Ardickas Z; Alexander KR; Wilensky JT
    J Glaucoma; 2003 Apr; 12(2):134-8. PubMed ID: 12671468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension.
    Tyler CW
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):204-12. PubMed ID: 7461923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results.
    Johnson CA; Brandt JD; Khong AM; Adams AJ
    Arch Ophthalmol; 1995 Jan; 113(1):70-6. PubMed ID: 7826296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?
    Schrems WA; Schrems-Hoesl LM; Mardin CY; Laemmer R; Kruse FE; Horn FK
    J Glaucoma; 2017 Apr; 26(4):373-382. PubMed ID: 28118204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: a prospective study.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    JAMA Ophthalmol; 2014 Jan; 132(1):77-83. PubMed ID: 24177945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Motion-on-Color Paradigm for Isolating Magnocellular Pathway Function in Preperimetric Glaucoma.
    Wen W; Zhang P; Liu T; Zhang T; Gao J; Sun X; He S
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4439-46. PubMed ID: 26193920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive visual field defects from experimental glaucoma: measurements with white and colored stimuli.
    Harwerth RS; Smith EL; Chandler M
    Optom Vis Sci; 1999 Aug; 76(8):558-70. PubMed ID: 10472962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma.
    Teesalu P; Airaksinen PJ; Tuulonen A
    Ophthalmology; 1998 Nov; 105(11):2077-81. PubMed ID: 9818609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Static versus kinetic testing in the nasal peripheral field in patients with glaucoma.
    Stewart WC
    Acta Ophthalmol (Copenh); 1992 Feb; 70(1):79-84. PubMed ID: 1557979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental glaucoma: perimetric field defects and intraocular pressure.
    Harwerth RS; Smith EL; DeSantis L
    J Glaucoma; 1997 Dec; 6(6):390-401. PubMed ID: 9407368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of frequency-doubling perimetry with retinal nerve fiber layer thickness and optic disc size in ocular hypertensives and glaucoma suspects.
    Kaushik S; Pandav SS; Ichhpujani P; Gupta A
    J Glaucoma; 2011 Aug; 20(6):366-70. PubMed ID: 20717056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.